Technology | 2009.09.15
University of Maryland Greenebaum Cancer Center the Latest Top Cancer Center to Adopt Calypso Medical’s “GPS for the Body” Tumor-Tracking Technology
SEATTLE--(BUSINESS WIRE)--Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, announced today that the University of Maryland Marlene and Stewart Greenebaum Cancer Center, a National Cancer Institute-designated cancer center in Baltimore, now offers the Calypso® System to provide accurate, precise, real-time tumor tracking for cancer patients undergoing external beam radiation therapy. With this installation, n
For more information, please visit
http://www.businesswire.com/news/home/20090914005170/en
